Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 50003528
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50005711(GNF-Pf-1011 | CHEBI:46024 | TRICHOSTATIN | Trichos...)
Affinity DataIC50: 4.60nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472331(CHEMBL419716)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472342(CHEMBL101167)
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472341(CHEMBL100282)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM19410(benzamide-type inhibitor, 3 | CHEMBL27759 | pyridi...)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472335(CHEMBL421589)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472338(CHEMBL321283)
Affinity DataIC50: 7.70E+3nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472339(CHEMBL319375)
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472336(CHEMBL321105)
Affinity DataIC50: 4.40E+4nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472337(CHEMBL99835)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472334(CHEMBL99853)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472332(CHEMBL317252)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472333(CHEMBL100925)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472340(CHEMBL100631)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50472343(CHEMBL99737)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed
TargetHistone deacetylase(Human)
Mitsui Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50079401(Sodium butyrate | CHEMBL62381 | butanoate | butyra...)
Affinity DataIC50: 1.40E+5nMAssay Description:Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2020
Entry Details Article
PubMed